Article Information
History
- November 16, 2022.
Article Versions
- Version 1 (November 21, 2021 - 11:16).
- Version 2 (March 11, 2022 - 09:12).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Niklas Bobrovitz*,1,2,3,†,
- Kim Noël*,4,
- Zihan Li5,
- Christian Cao6,
- Gabriel Deveaux3,
- Anabel Selemon6,
- David A. Clifton7,
- Mercedes Yanes-Lane8,
- Tingting Yan1 and
- Rahul K. Arora3,7
- 1Temerty Faculty of Medicine, University of Toronto
- 2Department of Critical Care Medicine, University of Calgary
- 3Centre for Health Informatics, University of Calgary
- 4Faculty of Medicine and Health Sciences, McGill University
- 5Faculty of Engineering, University of Waterloo
- 6Cumming School of Medicine, University of Calgary
- 7Institute of Biomedical Engineering, University of Oxford
- 8COVID-19 Immunity Task Force, McGill University
- ↵†Corresponding author:
Niklas Bobrovitz, niklas.bobrovitz{at}mail.utoronto.ca, Medical Sciences Building, 1 King’s College Cir, Toronto, ON M5S 1A8
↵* Contributed equally as co-first authors
Posted November 16, 2022.
SeroTracker-RoB: a decision rule-based algorithm for reproducible risk of bias assessment of seroprevalence studies
